** Shares of metabolic health solutions firm ReShape Lifesciences RSLS.O fall 57.5% to $1 premarket
** On Saturday, RSLS said it is raising $6 mln through a public offering of shares and warrants
** Co selling ~2.6 mln units, each consisting of one share and one warrant, at $2.33 per unit
** Warrants can be exercised at a price of $5.83 per share, after stockholder approval
** Maxim Group LLC is acting as the sole agent for the offering
** RSLS fell ~71% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。